We are live on ! Find out more
CELG.RT

Bristol-Myers Squibb Rights
CELG.RT

18 hedge funds and large institutions have $5.17M invested in Bristol-Myers Squibb Rights in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,336% more capital invested

Capital invested by funds: $150K → $5.17M (+$5.02M)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

0% less ownership

Funds ownership: 0.03% → 0.02% (-0%)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
3
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.84K
2
Mariner
Mariner
Kansas
+$1.08K
3
UBS Group
UBS Group
Switzerland
+$172
4
Morgan Stanley
Morgan Stanley
New York
+$14
5
RIL
Rothschild Investment LLC
Illinois
+$14

Top Sellers

Rank Fund Capital Flow
1
MS
Maven Securities
Jersey
-$46.8K
2
DC
Davenport & Co
Virginia
-$596
3
Citadel Advisors
Citadel Advisors
Florida
-$170
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
1
FourWorld Capital Management
New York
$5.13M – – –
TCA
2
Transcend Capital Advisors
New Jersey
$10.6K – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$8.05K +$1.84K +21,617 +32%
DC
4
Davenport & Co
Virginia
$7.56K -$596 -7,000 -8%
Citadel Advisors
5
Citadel Advisors
Florida
$3.48K -$170 -2,001 -5%
Fifth Third Bancorp
6
Fifth Third Bancorp
Ohio
$1.8K – – –
PAG
7
Private Advisor Group
New Jersey
$1.35K – – –
Mariner
8
Mariner
Kansas
$1.15K +$1.08K +12,730 New
TPA
9
Trivium Point Advisory
Connecticut
$900 – – –
UBS Group
10
UBS Group
Switzerland
$182 +$172 +2,016 +20,160%
Bank of America
11
Bank of America
North Carolina
$147 – – –
Morgan Stanley
12
Morgan Stanley
New York
$30 +$14 +164 +100%
Northwestern Mutual Wealth Management
13
Northwestern Mutual Wealth Management
Wisconsin
$22 – – –
RIL
14
Rothschild Investment LLC
Illinois
$15 +$14 +166 New
OC
15
Oakworth Capital
Alabama
$11 – – –
Wells Fargo
16
Wells Fargo
California
$3 – +3 +11%
JP Morgan Chase
17
JP Morgan Chase
New York
$2 +$2 +23 New
MS
18
Maven Securities
Jersey
– -$46.8K -67,856 Closed

CELG.RT Hedge Fund Activity: Q4 2023 in Review

18 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q4 2023, worth a combined $5.17M — up 3,336% from $150K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CELG.RT positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $1.84K. The largest seller was Maven Securities, exiting entirely with an estimated $46.8K sold.

  • 18 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q4 2023, up from 16 in Q3 2023.
  • Funds reported $5.17M of Bristol-Myers Squibb Rights stock for Q4 2023, up 3,336% quarter-over-quarter.
  • 3 funds opened new Bristol-Myers Squibb Rights positions in Q4 2023 and 1 closed out, a net change of +2 holders.
  • The largest Bristol-Myers Squibb Rights buyer in Q4 2023 was Susquehanna International Group, an estimated $1.84K added.
  • The largest Bristol-Myers Squibb Rights seller in Q4 2023 was Maven Securities, an estimated $46.8K sold.

Based on aggregated 13F filings for Q4 2023.